Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients (Q43788666)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 May 2008
edit
Language Label Description Also known as
English
Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients
scientific article published on 15 May 2008

    Statements

    Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients (English)
    0 references
    0 references
    R Charles Coombes
    Kaiyumars B Contractor
    Terence J Spinks
    Matthias Glaser

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit